June 4, 2023

As with many things in life, change is challenging, often undetected when it starts, many times mislabeled as an aberration, but always important. As John F. Kennedy once said...

June 1, 2023

Once the first Humira biosimilar, Amjevita, launched in the United States in January, payers needed to begin making decisions about coverage not only for Amjevita but for all the other Humira...

April 6, 2023

Health insurers are required to hold minimum levels of surplus each year. However, the exact amount a health insurer chooses to hold can vary significantly from one insurer to the next...

March 24, 2023

For a healthcare system to run efficiently there is a balance that needs to be found where there is adequate staffing to accommodate the needs of a population. Too much staffing and supply...

March 17, 2023

In the world of employee benefits, organizations and brokers often find themselves struggling to get a clear picture of the entire health benefits landscape. For self-funded groups, the challenge lies in managing...

February 10, 2023

There is a coming wave of changes arriving soon to the pharmacy market in the form of biosimilars.  And that coming wave has a big event in 2023:  the launch of Humira biosimilars, which...

February 8, 2023

About 30 years ago I met with my then-business partner to think into the future and try to anticipate what we might see in terms of changes in the healthcare system.  The results of this challenging process were...

January 31, 2023

Today is the day!  The Big Event of 2023 is the launch of multiple Humira biosimilars which begins today with the arrival of Amgen’s Amjevita on the market.  The launch of Amjevita is the first step in the Big Event...

January 27, 2023

There is a big wave of changes coming to the pharmacy market. The extent of the impact this wave will bring is not yet fully known, but there are trends we can follow that help predict what this change will look like...